Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2017: 3.556

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 36, Issue 5

Issues

Urinary α1-Microglobulin Detects Uropathy. A Prospective Study in 483 Urological Patients

Karel Everaert / Joris Delanghe / Christophe Vande Wiele / Piet Hoebeke / Rudy A. Dierckx / Bart Clarysse / Norbert Lameire / Willem Oosterlinck
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.052

Abstract

Purpose: The aim of the study was to evaluate prospectively urinary α1-microglobulin as a marker of proximal tubular damage following acute pyelonephritis and outflow disease of the upper urinary tract in a urological population with minimal exclusion criteria. We also measured the urinary γ-glutamyltransferase activity, urinary albumin, urinary and serum creatinine, serum IgA and serum α1-microglobulin.

Patients and methods: We studied 483 urological patients (age: 1 to 92 years, 297 men, 186 women) excluding patients receiving nephrotoxic drugs, or suffering from type 1 diabetes or renal diseases. There were 141 patients with urinary tract infection but no fever, 36 patients with high fever of non-renal origin, 51 patients with acute pyelonephritis and 156 patients with outflow disease of the upper tract, and 99 patients were incluced in the reference population.

Results: For acute pyelonephritis, vesico-ureteral reflux, and ureteral obstruction, urinary α1-microglobulin had a sensitivity of 94%, 90% and 63% respectively and a specificity of 67%, 77% and 76%. The area under the curve of the receiver operator characteristic curve was significantly (p < 0.001) higher for urinary α1-microglobulin than for albumin or γ-glutamyltransferase activity. Unexpected positive results were found in acute prostatitis. The urinary α1-microglobulin was the only parameter which differentiated between acute prostatitis and pyelonephritis (p < 0.001). Creatinine clearance or age had little and gender had no influence on the urinary excretion of α1-microglobulin. Urine production rate significantly increases the urinary α1-microglobulin/creatinine ratio.

Conclusion: Our results suggest that the urinary α1-microglobulin/creatinine ratio is a diagnostically useful marker of tubular damage in acute pyelonephritis and vesico-ureteral reflux in the urological population. Following renal colic and chronic ureteral obstruction, a significant increase in urinary α1-microglobulin excretion was observed.

About the article

Published Online: 2005-06-01

Published in Print: 1998-05-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 36, Issue 5, Pages 309–315, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.052.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Anna Masajtis-Zagajewska and Michal Nowicki
Clinica Chimica Acta, 2017, Volume 471, Page 286
[2]
J. Delanghe
Acta Clinica Belgica, 2007, Volume 62, Number 3, Page 155
[3]
K. Everaert, N. Lumen, W. Kerckhaert, P. Willaert, and M. van Driel
Acta Clinica Belgica, 2009, Volume 64, Number 4, Page 335
[4]
Naro Ohashi, Sayaka Ishigaki, Kazuto Kitajima, Naoko Tsuji, Shinsuke Isobe, Takamasa Iwakura, Masafumi Ono, Tomoyuki Fujikura, Takayuki Tsuji, Yukitoshi Sakao, Akihiko Kato, and Hideo Yasuda
Clinical and Experimental Nephrology, 2015, Volume 19, Number 5, Page 851
[5]
A. Soggiu, C. Piras, L. Bonizzi, H. A. Hussein, S. Pisanu, and P. Roncada
Acta Diabetologica, 2012, Volume 49, Number 6, Page 453
[7]
Frederiek D’Hondt and Karel Everaert
Current Infectious Disease Reports, 2011, Volume 13, Number 6, Page 544
[8]
Joris Penders and Joris R Delanghe
Clinica Chimica Acta, 2004, Volume 346, Number 2, Page 107
[9]
K. Everaert, P. Hoebeke, and J. Delanghe
Clinica Chimica Acta, 2000, Volume 297, Number 1-2, Page 183
[10]
Karel Everaert, Joris Delanghe, Marc Vanderkelen, Kristof Cornelis, Stefaan De Wachter, Annick Viaene, Eddy De Ruyck, Bart Clarysse, and Willem Oosterlinck
Clinical Chemistry and Laboratory Medicine, 2003, Volume 41, Number 1
[11]
Richard S Lee
Current Opinion in Urology, 2009, Volume 19, Number 4, Page 397
[12]
A. Faulí, C. Gomar, J. M. Campistol, L. Alvarez, A. M. Manig, and P. Matute
European Journal of Anaesthesiology, 2003, Volume 20, Number 6, Page 443
[13]
S. Conrad
Der Urologe, 2007, Volume 46, Number 2, Page 124
[14]
A. Faulí, C. Gomar, J. M. Campistol, L. Alvarez, A. M. Manig, and P. Matute
European Journal of Anaesthesiology, 2005, Volume 20, Number 6, Page 443
[15]
Barbara Suwelack, Viola Kobelt, Matthias Erfmann, Martin Hausberg, Ulf Gerhardt, Karl-Heinz Rahn, and Helge Hohage
Transplant International, 2003, Volume 16, Number 5, Page 313

Comments (0)

Please log in or register to comment.
Log in